Viewing Study NCT02834858


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-03-07 @ 7:22 PM
Study NCT ID: NCT02834858
Status: UNKNOWN
Last Update Posted: 2017-04-06
First Post: 2016-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications
Sponsor: Jie Shen
Organization:

Study Overview

Official Title: Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications
Status: UNKNOWN
Status Verified Date: 2017-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Stem cell therapy has been a new and effective therapy in recent years for diabetic foot.This study intends to establish an optimal clinical research program, and attempts to break the technical bottleneck in the stem cell therapy for treating diabetes related vascular complications.
Detailed Description: Diabetic foot is one of the most serious chronic complications of diabetic patients, and still lacking effective treatments.

Stem cell therapy has been a new and effective therapy in recent years for diabetic foot. Combined with the previous studies of the investigators research group, this study intends to transform part of the results of this research, establish an optimal clinical research program, and attempts to break the technical bottleneck in the stem cell therapy for treating diabetes related vascular complications.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: